Cross-Border Incubation Expertise Accelerates AI, Biotech, and Fintech Ventures
Former “Top 10 International Youth Maker” brings invaluable experience to enhance startup growth in Vancouver and Silicon Valley.
VANCOUVER, BC and PALO ALTO, Calif., Dec. 23, 2025 /PRNewswire/ — US CAN STARTUP, a preeminent cross-border incubation platform and venture capital entity, has unveiled a set of strategic investments aimed at high-potential North American startups, including Kalino Bio and AllScale.io.
This strategic initiative signifies a pivotal moment for founder Shun Ma, who is now extending his “impact incubation” paradigm from Asia onto the global arena.
The Visionary Leadership of Shun Ma
Majoring in a decade’s worth of expertise in entrepreneurship education and venture financing, Mr. Ma has established US CAN STARTUP as a vital conduit for innovation.
Recently, the firm confirmed its role as a principal investor in Kalino Bio, a revolutionary biotech firm launched by Dr. Sherry Zhao, which specializes in developing non-surgical immunocontraceptive methods for animals.
It has also backed AllScale.io, a self-custody neobank designed for micro-businesses, co-founded by seasoned entrepreneurs Shawn Pang and Leo Wang.
“Our mission is to identify and amplify founders tackling core issues with scalable technology,” stated Shun Ma, Founder and CEO of US CAN STARTUP.
“Both Kalino Bio and AllScale are emblematic of the future trajectories of their sectors. By extending not merely financial support but also strategic international resources, we strive to hasten their ascent to market leadership.”
A Legacy of Innovation
Shun Ma’s odyssey in the startup landscape is well documented. In 2015, he was celebrated as one of the “Top 10 International Youth Makers” by the Cyberspace Administration of China, acknowledging the most promising young innovators in the nation.
Since then, Ma has played a mentoring role to thousands of entrepreneurs. His current position as a Limited Partner in the WUTIF Capital (Western Universities Technology Innovation Fund) and Managing Partner at Leading Impact Capital further cements his influence in the North American investment milieu.
“Shun embodies an unparalleled fusion of operational fortitude and investment acumen,” commented Jessica Dai, co-founder of Xlens.ca. “His background as an elite ultra-marathon runner mirrors his business philosophy—building a unicorn is an enduring endeavor, not a fleeting race.”
Through US CAN STARTUP, Ma continues to supervise a diverse portfolio of more than 10 companies, including OptHealth.ai, an AI-driven ophthalmic health solution poised to enter the retail sphere.
Source link: Prnewswire.com.
